瑞可達(688800.SH):擬將“新能源汽車關鍵零部件項目”、“研發中心項目”延期
格隆匯1月11日丨瑞可達(688800.SH)公佈,自2022年9月募集資金到賬以來,公司積極推進募投項目的實施,因基礎建設前置審批程序的進度較原預期時間有所延後,公司於2023年5月取得建設用地規劃許可證及建設工程規劃許可證,並於2023年6月29日取得建築工程施工許可證,造成了募投項目開工及建設進度有所延遲。根據募投項目當前實際建設情況,在募投項目實施主體、資金用途不發生變更的前提下,為嚴格把控項目整體質量,保障募投項目順利開展,公司經審慎研究,擬將“新能源汽車關鍵零部件項目”、“研發中心項目”達到預定可使用狀態日期進行調整。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.